Gabelli & CO Investment Advisers, Inc. Bausch Health Companies Inc. Transaction History

Gabelli & CO Investment Advisers, Inc.

$535 Million
Q3 2024

A detailed history of Gabelli & CO Investment Advisers, Inc. transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Gabelli & CO Investment Advisers, Inc. holds 11,500 shares of BHC stock, worth $84,985. This represents 0.02% of its overall portfolio holdings.

Number of Shares

11,500

Previous 14,200 19.01%

Holding current value

$84,985

Previous $98,000 5.1%

% of portfolio

0.02%

Previous 0.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$5.22 - $8.26 $14,094 - $22,302	-2,700 Reduced 19.01%	11,500 $93,000
Q1 2024 May 14, 2024	SELL	$7.77 - $10.61 $16,317 - $22,281	-2,100 Reduced 12.88%	14,200 $150,000
Q4 2023 Feb 13, 2024	SELL	$6.53 - $8.23 $6,530 - $8,230	-1,000 Reduced 5.78%	16,300 $130,000
Q2 2023 Aug 10, 2023	SELL	$5.72 - $8.8 $4,576 - $7,040	-800 Reduced 4.42%	17,300 $138,000
Q4 2022 Feb 13, 2023	BUY	$6.09 - $7.93 $18,879 - $24,583	3,100 Added 20.67%	18,100 $113,000
Q3 2022 Nov 10, 2022	BUY	$4.58 - $9.21 $22,900 - $46,050	5,000 Added 50.0%	15,000 $103,000
Q2 2022 Aug 12, 2022	SELL	$7.06 - $23.63 $48,008 - $160,684	-6,800 Reduced 40.48%	10,000 $84,000
Q3 2021 Nov 12, 2021	SELL	$25.04 - $30.06 $12,520 - $15,030	-500 Reduced 2.89%	16,800 $468,000
Q2 2021 Aug 13, 2021	SELL	$27.43 - $32.7 $46,631 - $55,590	-1,700 Reduced 8.95%	17,300 $507,000
Q1 2021 May 14, 2021	SELL	$21.37 - $34.38 $149,590 - $240,660	-7,000 Reduced 26.92%	19,000 $603,000
Q4 2020 Feb 05, 2021	SELL	$15.31 - $21.12 $50,523 - $69,696	-3,300 Reduced 11.26%	26,000 $541,000
Q3 2020 Nov 06, 2020	BUY	$14.88 - $20.13 $130,944 - $177,144	8,800 Added 42.93%	29,300 $455,000
Q2 2020 Aug 13, 2020	BUY	$13.31 - $20.51 $59,895 - $92,295	4,500 Added 28.13%	20,500 $375,000
Q1 2020 May 14, 2020	BUY	$12.98 - $30.25 $80,476 - $187,550	6,200 Added 63.27%	16,000 $248,000
Q4 2019 Feb 14, 2020	SELL	$18.89 - $31.89 $37,780 - $63,780	-2,000 Reduced 16.95%	9,800 $293,000
Q3 2019 Nov 01, 2019	BUY	$20.88 - $25.66 $246,384 - $302,788	11,800 New	11,800 $258,000

Others Institutions Holding BHC

# of Institutions

254

Shares Held

253M

Call Options Held

5.53M

Put Options Held

16.5M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli & CO Investment Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gabelli & CO Investment Advisers, Inc. with notifications on news.

Account

Gabelli & CO Investment Advisers, Inc. Bausch Health Companies Inc. Transaction History